Related Experiment Video
Updated: Jan 23, 2026

Defining Substrate Specificities for Lipase and Phospholipase Candidates
Published on: November 23, 2016
Lysosomal acid lipase deficiency - early diagnosis is the key
Georg Strebinger1, Elena Müller1, Alexandra Feldman1
1First Department of Medicine, Paracelsus Medical University, Salzburg, Austria.
Insights
Lysosomal acid lipase deficiency (LAL-D) is a rare genetic disorder. Early diagnosis is crucial for effective enzyme replacement therapy, especially in adults presenting with metabolic syndrome-like symptoms.
Area of Science:
- Biochemistry
- Genetics
- Pediatrics
- Internal Medicine
Background:
- Lysosomal acid lipase deficiency (LAL-D) is an ultra-rare genetic disorder affecting lysosomal function.
- Disease presentation varies significantly, from severe infantile forms to milder adult variants.
- Milder LAL-D often goes undiagnosed due to non-specific symptoms mimicking metabolic syndrome.
Purpose of the Study:
- To highlight key clinical scenarios for recognizing LAL-D in pediatric and adult patients.
- To emphasize the importance of considering LAL-D in differential diagnoses.
- To inform clinicians about newly available enzyme replacement therapy and diagnostic tests.
Main Methods:
- Literature review focusing on clinical presentations of LAL-D.
- Analysis of diagnostic challenges and therapeutic advancements.
- Identification of specific patient profiles warranting LAL-D investigation.
Main Results:
- LAL-D can present with progressive fatty liver, splenomegaly, dyslipidemia, and premature atherosclerosis.
- Adult LAL-D is frequently misdiagnosed or overlooked due to overlapping symptoms with common metabolic conditions.
- A dried blood spot test offers a simple method for LAL-D diagnosis or exclusion.
Conclusions:
- Increased clinical awareness of LAL-D is essential for timely diagnosis.
- Prompt diagnosis facilitates access to life-saving enzyme replacement therapy.
- Utilizing the dried blood spot test can significantly improve LAL-D detection rates.
Abstract:
Lysosomal acid lipase deficiency (LAL-D) is an ultra-rare lysosomal storage disease that may present from infancy to late adulthood depending on residual enzyme activity. While the severe form manifests as a rapidly progressive disease with near universal mortality within the first 6 months of life, milder forms frequently go undiagnosed for prolonged periods and typically present with progressive fatty liver disease, enlarged spleen, atherogenic dyslipidemia and premature atherosclerosis. The adult variant of LAL-D is typically diagnosed late or even overlooked due to the unspecific nature of the presenting symptoms, which are similar to common changes observed in the context of the metabolic syndrome. This review is aimed at delineating clinically useful scenarios in which pediatric or adult medicine clinicians should be aware of LAL-D as a differential diagnosis for selected patients. This is particularly relevant as a potentially life-saving enzyme replacement therapy has become available and the diagnosis can easily be ruled out or confirmed using a dried blood spot test.
Related Concept Videos
Key Elements for Plant Nutrition
Lysosomes
Lysosomal Hydrolases
Key Techniques in Microbiology
Delivery Pathways to the Lysosome
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Nursing Diagnosis
The nursing diagnosis focuses on evidence-based...

